Training activity information
Details
Critically appraise and present new bioinformatics methods and asses clinical use in haematological oncology
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Impact on service delivery
- Integration with existing systems
- Literature and evidence base
- New laboratory technologies
- Advances in methodologies and algorithms
- Service improvement
- Improvements to patient care
- Evaluation of developments
- Standards of care and guidelines
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What new bioinformatics methods will you be appraising? What aspects of their clinical use in haematological oncology will you assess?
- How will you develop your skills in critically evaluating new bioinformatics methods? What will you learn about the challenges and opportunities of applying these methods in a clinical setting for haematological oncology?
- Will you research new bioinformatics methods relevant to haematological oncology? Will you consider how these methods could be applied clinically? Have you discussed potential methods to appraise with your training officer?
In action
- Which new bioinformatics methods are you critically appraising? What criteria are you using for the appraisal? How are you assessing their potential clinical use in haematological oncology? How are you structuring your presentation?
- Are you able to identify the key strengths and limitations of the new methods? Are you developing a clear understanding of their potential clinical applications and challenges in haematological oncology? Is your presentation effectively conveying this information?
- If you find conflicting information about the methods, how are you evaluating it? Are you adjusting your presentation based on the assumed knowledge of your audience? Are you prepared to discuss potential ethical or practical implications specific to haematological oncology?
On action
- Describe the new bioinformatics method(s) you critically appraised. What were the key aspects of their methodology and potential clinical applications in haematological oncology? Summarise your critical appraisal and your assessment of their clinical use.
- What criteria did you use to critically appraise the new methods (e.g., novelty, validity, feasibility, impact)? What factors did you consider when assessing their potential clinical use in the context of haematological oncology? Were there any unexpected strengths or limitations of the methods you identified? What did you learn from these? How did your analytical and presentation skills (‘reflect-in-action’) shape your appraisal and assessment? How does the ability to critically appraise new methods relate to the advancement and adoption of innovative bioinformatics approaches in clinical practice, specifically in haematological oncology?
- What aspects of critical appraisal of scientific methods do you want to develop further? How can you effectively communicate your appraisal and assessment to different audiences? What specific actions / ‘next steps’ will you now take to enhance your skills in this area? What support or resources might you need to further develop your expertise in evaluating bioinformatics methods relevant to cancer genomics?
Beyond action
- Have you encountered new bioinformatics methods specifically applied to haematological oncology since this training activity? How did your previous appraisal experience help you understand their potential? Did the audience and context of your presentation in this training activity differ from other presentations you have given? How did you adapt your approach, drawing on your reflections from this experience? Have you discussed the challenges and opportunities of bioinformatics in haematological oncology with colleagues? Did your work on this training activity inform these discussions?
- Are you more aware of the specific bioinformatics challenges and requirements within haematological oncology due to this training activity? Has your ability to tailor your presentation of technical information to a specific clinical domain improved as a result of this activity? Have the critical appraisal skills developed here been useful in evaluating research papers or guidelines related to bioinformatics in haematological oncology?
- How might your understanding of bioinformatics methods in haematological oncology be relevant to future service development or research projects in this area? In what ways will your experience in presenting complex information in this specific clinical context be valuable in multidisciplinary team meetings or when communicating with clinical colleagues? What further learning or experiences would help you to deepen your expertise in bioinformatics methods for haematological oncology?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 5 |
Outcome
Critically appraise new technologies and methods objectively. |
| # 7 |
Outcome
Practice in accordance with relevant standards and guidance. |